Design and In Vivo Characterization of Immunoconjugates Targeting HIV gp160. - Wikidata - wikimedia - TriplyDB

Design and In Vivo Characterization of Immunoconjugates Targeting HIV gp160.

Design and In Vivo Characterization of Immunoconjugates Targeting HIV gp160.

http://www.wikidata.org/entity/Q37593171

about

Identification of Human Anti-HIV gp160 Monoclonal Antibodies That Make Effective Immunotoxins.Selective cytotoxicity of a novel immunotoxin based on pulchellin A chain for cells expressing HIV envelope.Increasing the Clinical Potential and Applications of Anti-HIV Antibodies.

P2860

Q37593177-FCF570C9-04E9-43AC-90EB-01F2E3D74ED2 Q40101404-EEA356B9-DF27-4804-805E-D8610920A2AA Q47110966-05AF12C1-C9C3-497D-A947-7238B9D8860C

P2860

Design and In Vivo Characterization of Immunoconjugates Targeting HIV gp160.

http://www.wikidata.org/entity/Q37593171

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 19 October 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Design and In Vivo Characterization of Immunoconjugates Targeting HIV gp160.

@en

Design and In Vivo Characterization of Immunoconjugates Targeting HIV gp160.

@nl

type

label

Design and In Vivo Characterization of Immunoconjugates Targeting HIV gp160.

@en

Design and In Vivo Characterization of Immunoconjugates Targeting HIV gp160.

@nl

prefLabel

Design and In Vivo Characterization of Immunoconjugates Targeting HIV gp160.

@en

Design and In Vivo Characterization of Immunoconjugates Targeting HIV gp160.

@nl

P1433

Q37593171-D839F53C-864B-439D-86F2-1A7917F60159

P1476

Q37593171-75A9EFDE-4450-4C1B-82FF-B9B8429859BE

P2093

Q37593171-0F1D2039-DA99-41B5-97FD-927D1CB78CE8

Q37593171-12D7F801-1F96-4498-BD80-47D7F6535CBF

Q37593171-21047C7A-F915-49B6-B02E-DB876A3D2D98

Q37593171-4A80654B-BD44-4B9B-95C5-13B26C38AB00

Q37593171-4C1E7954-9E59-4695-8896-48191E7B41EE

Q37593171-590C2085-BD1E-4A64-ADCB-32E41A569692

Q37593171-5D08F7E1-A8D8-41AD-B163-D1A9F317D828

Q37593171-657CE51D-7F6D-4A7A-8077-1A38560BBE33

Q37593171-65988A5B-63AA-426F-B10F-AF7DC1C9D6DE

Q37593171-7478D8B7-6A6B-4124-AC9E-6E12291C014E

P2860

Q37593171-09FBA1D1-0248-4FD1-A29D-DED6AB698298

Q37593171-0EDDD005-EF72-42B7-B6CD-28C4EC690C70

Q37593171-1AC62315-EC5E-46B3-950A-5421A2028223

Q37593171-208D6259-595D-4AEA-87EE-774BBEBB2825

Q37593171-213388D2-8278-4413-BD89-837211576255

Q37593171-243E0F24-E589-4A14-9203-622D94AF29FF

Q37593171-24771695-2063-4E58-B1A8-501A68E82B85

Q37593171-2654B6FE-7814-4223-ACE2-0083E06762C3

Q37593171-34DF0B69-D091-4731-88FD-F873FCD65918

Q37593171-3F5300B9-9BAA-4C83-8CCF-A8AA3E54C7F8

P31

Q37593171-1379A422-8832-4360-B1E2-D4C3842BCF6C

P356

Q37593171-3FF2F932-B92E-4F3F-AED8-84CF956EDC7E

P407

Q37593171-71F016F6-37AC-4A54-BDC2-2214D5070C84

P433

Q37593171-60558163-0178-4CBA-9B96-E457FF87C244

P478

Q37593171-B1CFD01C-9AC1-4A6C-8CF4-F8937C923099

P577

Q37593171-6C029962-CC82-417D-A06A-49FDB05CB036

P698

Q37593171-34943B9C-302B-4B7D-8CB4-47C1D21AEB8B

P932

Q37593171-BFD19A30-6483-4267-892C-2E7ECAB4DAEF

P356

P1433

Journal of Virology

P1476

Design and In Vivo Characterization of Immunoconjugates Targeting HIV gp160.

@en

P2093

Anderson Frank

http://www.w3.org/2001/XMLSchema#string

Cody P Coyne

http://www.w3.org/2001/XMLSchema#string

David Worthylake

http://www.w3.org/2001/XMLSchema#string

Dean H Hamer

http://www.w3.org/2001/XMLSchema#string

Deborah Weiss

http://www.w3.org/2001/XMLSchema#string

Ellen S Vitetta

http://www.w3.org/2001/XMLSchema#string

Gang Chen

http://www.w3.org/2001/XMLSchema#string

Grace A Maresh

http://www.w3.org/2001/XMLSchema#string

Hye-Kyung Chung

http://www.w3.org/2001/XMLSchema#string

James E Robinson

http://www.w3.org/2001/XMLSchema#string

P2860

Antibody to ricin a chain hinders intracellular routing of toxin and protects cells even after toxin has been internalized

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Targeted cytotoxic therapy kills persisting HIV infected cells during ART

Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy

Pre-clinical evaluation of a 213Bi-labeled 2556 antibody to HIV-1 gp41 glycoprotein in HIV-1 mouse models as a reagent for HIV eradication

Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone

Design and synthesis of N-maleimido-functionalized hydrophilic polymers via copper-mediated living radical polymerization: a suitable alternative to PEGylation chemistry.

Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys.

Human immunodeficiency virus-infected T cells and monocytes are killed by monoclonal human anti-gp41 antibodies coupled to ricin A chain.

Immunologic strategies for HIV-1 remission and eradication.

P31

scholarly article

P356

10.1128/JVI.01360-16

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

91

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27795412

http://www.w3.org/2001/XMLSchema#string

P932

5244325

http://www.w3.org/2001/XMLSchema#string